What does APOTHEEK BEAUJEAN CENTRUM do?

APOTHEEK BEAUJEAN CENTRUM is a pharmacy in Halle. Private Limited, started on 1 July 1977, 1 establishment.

What is the address of APOTHEEK BEAUJEAN CENTRUM?

The registered office of APOTHEEK BEAUJEAN CENTRUM is located at Ninoofsesteenweg 30, 1500 Halle.

Is APOTHEEK BEAUJEAN CENTRUM still active?

Yes. According to the CBE (29 October 2026) APOTHEEK BEAUJEAN CENTRUM is active, legal situation “Normale toestand”, started on 1 July 1977.

Is APOTHEEK BEAUJEAN CENTRUM registered on Peppol?

Yes, APOTHEEK BEAUJEAN CENTRUM is registered on the Peppol network with ID 0208:0417394958.

What is the enterprise number of APOTHEEK BEAUJEAN CENTRUM?

The enterprise number of APOTHEEK BEAUJEAN CENTRUM is BE0417394958.

When was APOTHEEK BEAUJEAN CENTRUM founded?

APOTHEEK BEAUJEAN CENTRUM was founded on 1 July 1977.

Is APOTHEEK BEAUJEAN CENTRUM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 July 1977; 4 annual accounts filed, latest fiscal year 2026; 7 directors known from the annual account.

How much profit did APOTHEEK BEAUJEAN CENTRUM make in 2026?

APOTHEEK BEAUJEAN CENTRUM posted a profit after taxes of € 132,957 in financial year 2026.

What is the revenue of APOTHEEK BEAUJEAN CENTRUM?

As a small company, APOTHEEK BEAUJEAN CENTRUM is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 603,478.

How much does an employee at APOTHEEK BEAUJEAN CENTRUM earn?

The average wage cost per full-time employee at APOTHEEK BEAUJEAN CENTRUM was € 68,100 in 2026: staff costs of € 306,512 for 4.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK BEAUJEAN CENTRUM have?

According to the 2026 annual accounts, APOTHEEK BEAUJEAN CENTRUM has 4.5 full-time equivalents (FTE).

APOTHEEK BEAUJEAN CENTRUM (Private Limited) - Halle

Q: Who are the directors of APOTHEEK BEAUJEAN CENTRUM?

According to the 2026 annual accounts, the directors of APOTHEEK BEAUJEAN CENTRUM are: Peter Vanbellingen, Goethaert Stefan, Kris Castelein, Michael Hamelrijck, Jo Willemyns, GJ Lifescience management SRL, Stefaan Vandamme.

Dossier APOTHEEK BEAUJEAN CENTRUM, printed on 29 October 2026 from databakkes.be/en/0417394958/apotheek-beaujean-centrum. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 33 % of short-term debt in 2026; threshold 65 %.

Financials

Financial year 2026

APOTHEEK BEAUJEAN CENTRUM from Halle, company number BE0417394958, closed financial year 2026 with a result of € 132,957 after tax. For that financial year APOTHEEK BEAUJEAN CENTRUM recorded a gross margin of € 603,478 and equity of € 346,449. Compared with financial year 2024, the result moved from € 72,287 to € 132,957. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 21, 2026.

What it is worth Growing

€ 346,449

▲ 62% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 132,957

▲ 84% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,905

▼ 92% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 327,849.

People and assets in 2026

Full-time equivalents

4.5

▲ 3.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 306,512

▲ € 255,986 vs 2024

€ 68,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 95,331

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

€ 977,733

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 201,818

▲ 69% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 1,856

▼ 87% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2026	Change 2024 → 2026
Gross margin	€ 105,410 Gross margin 2022: € 105,410 First fiscal year in the series	€ 108,000 Gross margin 2023: € 108,000 ▲ 2% vs 2022 (€ 105,410) Favourable step	€ 155,125 Gross margin 2024: € 155,125 ▲ 44% vs 2023 (€ 108,000) Favourable step	€ 603,478 Gross margin 2026: € 603,478 ▲ 289% vs 2024 (€ 155,125) Favourable step	▲ 289%
Profit after taxes	€ 45,296 Profit after taxes 2022: € 45,296 First fiscal year in the series	€ 28,509 Profit after taxes 2023: € 28,509 ▼ 37% vs 2022 (€ 45,296) Unfavourable step	€ 72,287 Profit after taxes 2024: € 72,287 ▲ 154% vs 2023 (€ 28,509) Favourable step	€ 132,957 Profit after taxes 2026: € 132,957 ▲ 84% vs 2024 (€ 72,287) Favourable step	▲ 84%
Equity	€ 212,696 Equity 2022: € 212,696 First fiscal year in the series	€ 216,205 Equity 2023: € 216,205 ▲ 2% vs 2022 (€ 212,696) Favourable step	€ 213,492 Equity 2024: € 213,492 ▼ 1% vs 2023 (€ 216,205) Unfavourable step	€ 346,449 Equity 2026: € 346,449 ▲ 62% vs 2024 (€ 213,492) Favourable step	▲ 62%
Total debts	€ 197,871 Total debts 2022: € 197,871 First fiscal year in the series	€ 214,612 Total debts 2023: € 214,612 ▲ 8% vs 2022 (€ 197,871) Unfavourable step	€ 226,809 Total debts 2024: € 226,809 ▲ 6% vs 2023 (€ 214,612) Unfavourable step	€ 1,193,116 Total debts 2026: € 1,193,116 ▲ € 966,308 vs 2024 (€ 226,809) Unfavourable step	▲ € 966,308
Cash	€ 156,067 Cash 2022: € 156,067 First fiscal year in the series	€ 146,274 Cash 2023: € 146,274 ▼ 6% vs 2022 (€ 156,067) Unfavourable step	€ 149,115 Cash 2024: € 149,115 ▲ 2% vs 2023 (€ 146,274) Favourable step	€ 11,905 Cash 2026: € 11,905 ▼ 92% vs 2024 (€ 149,115) Unfavourable step	▼ 92%
Retained profit	€ 194,096 Retained profit 2022: € 194,096 First fiscal year in the series	€ 197,605 Retained profit 2023: € 197,605 ▲ 2% vs 2022 (€ 194,096) Favourable step	€ 194,892 Retained profit 2024: € 194,892 ▼ 1% vs 2023 (€ 197,605) Unfavourable step	€ 327,849 Retained profit 2026: € 327,849 ▲ 68% vs 2024 (€ 194,892) Favourable step	▲ 68%
Dividend	€ 45,000 Dividend 2022: € 45,000 First fiscal year in the series	€ 25,000 Dividend 2023: € 25,000 ▼ 44% vs 2022 (€ 45,000) Unchanged	€ 75,000 Dividend 2024: € 75,000 ▲ 200% vs 2023 (€ 25,000) Unchanged	€ 0 Dividend 2026: € 0 ▼ 100% vs 2024 (€ 75,000) Unchanged	▼ 100%
Bank debt	€ 55,116 Bank debt 2022: € 55,116 First fiscal year in the series	€ 50,000 Bank debt 2023: € 50,000 ▼ 9% vs 2022 (€ 55,116) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 50,000) Favourable step	€ 977,733 Bank debt 2026: € 977,733 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 410,567 Balance sheet total 2022: € 410,567 First fiscal year in the series	€ 430,817 Balance sheet total 2023: € 430,817 ▲ 5% vs 2022 (€ 410,567) Unchanged	€ 440,301 Balance sheet total 2024: € 440,301 ▲ 2% vs 2023 (€ 430,817) Unchanged	€ 1,539,565 Balance sheet total 2026: € 1,539,565 ▲ 250% vs 2024 (€ 440,301) Unchanged	▲ 250%
Employees (FTE)	1.5 Employees (FTE) 2022: 1.5 First fiscal year in the series	1.6 Employees (FTE) 2023: 1.6 ▲ 0.1 vs 2022 (1.5) Unchanged	1.1 Employees (FTE) 2024: 1.1 ▼ 0.5 vs 2023 (1.6) Unchanged	4.5 Employees (FTE) 2026: 4.5 ▲ 3.4 vs 2024 (1.1) Unchanged	▲ 3.4

Key figures of APOTHEEK BEAUJEAN CENTRUM, fiscal years 2022 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to APOTHEEK BEAUJEAN CENTRUM?

What happened at APOTHEEK BEAUJEAN CENTRUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 21, 2026 New annual accounts for financial year 2026: profit of € 132,957 (▲ 84% vs 2024). Source: NBB ↗
2026 Michael Hamelrijck became a director. NBB
2026 Stefaan Vandamme stepped down as director. NBB
2025 Peter Vanbellingen became a director. NBB
2025 Goethaert Stefan became a director. NBB
2025 Kris Castelein became a director. NBB
2025 Jo Willemyns became a director. NBB
2025 GJ Lifescience management SRL became a director. NBB

In short

From € 45,296 profit in 2022 to € 132,957 profit in 2026.

Paid € 95,666 in corporate taxes since 2022.

Best year ever: 2026, with € 132,957 profit.

On average € 134,100 of value added per employee in 2026.

Original PDFs at the National Bank ↗

Management

NEWPHARMA GROUP 100%

EMSOFI 99.3%

The stake of NEWPHARMA GROUP, EMSOFI comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK BEAUJEAN CENTRUM

Behind APOTHEEK BEAUJEAN CENTRUM are Peter Vanbellingen, Goethaert Stefan, Kris Castelein, Michael Hamelrijck, Jo Willemyns and GJ Lifescience management SRL. The shares are held by NEWPHARMA GROUP (100%) and EMSOFI (99.3%).

Directors

According to the 2026 annual accounts

Peter Vanbellingen

Director

since 2025

Goethaert Stefan

Director · represented by Stefan Goethaert

Also active at: USIMEX - INVEST, Colruyt Group, DE PRINS RETAIL, VISIEBLE, RIVAN, JIMS Expansion, Holding De Prins, Fitness New Generation +8 more

since 2025

Kris Castelein

Director

since 2025

Michael Hamelrijck

Director

since 2026

Jo Willemyns

Director

since 2025

GJ Lifescience management SRL

Managing director · represented by Gilles Jourquin

Also active at: NEWPHARMA GROUP, Smartvalue, NEWPHARMA

since 2025

Stefaan Vandamme

Director

since 2025 · until 2026

Shareholders

NEWPHARMA GROUP

100%

EMSOFI

99.3%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Ninoofsesteenweg 30

1500 Halle

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0417.394.958

VAT number

BE 0417.394.958

Registered office

Ninoofsesteenweg 30, 1500 Halle

Names & denominations

APOTHEEK BEAUJEAN CENTRUM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 July 1977

Peppol

Active · Active since 4 Sept 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK BEAUJEAN CENTRUM

Warning lights

Financials

What happened to APOTHEEK BEAUJEAN CENTRUM?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions